Manipulating selectivity through gatekeeper interactions: Inhibition of EGFR and its T790M mutant

被引：0

作者：

Hanan, Emily ^{[1
]}

Bryan, Marian ^{[1
]}

Burdick, Daniel ^{[1
]}

Chan, Bryan ^{[1
]}

Chen, Yuan ^{[1
]}

Eigenbrot, Charles ^{[1
]}

Heald, Robert ^{[2
]}

Heffron, Timothy ^{[1
]}

La, Hank ^{[1
]}

Purkey, Hans ^{[1
]}

Schaefer, Gabriele ^{[1
]}

Schmidt, Stephen ^{[1
]}

Seward, Eileen ^{[2
]}

Sideris, Steve ^{[1
]}

Wang, Shumei ^{[1
]}

Yu, Christine ^{[1
]}

机构：

[1] Genentech Inc, San Francisco, CA USA

[2] Discovery Charles River, Harlow, Essex, England

来源：

ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY | 2016年 / 252卷

关键词：

D O I：

暂无

中图分类号：

O6 [化学];

学科分类号：

0703 ;

摘要：

620

引用

页数：1

共 50 条

[1] Inhibition of the T790M gatekeeper mutant of the epidermal growth factor receptor by EXEL-7647
Gendreau, Steven B.
Ventura, Richard
Keast, Paul
Laird, A. Douglas
Yakes, F. Michael
Zhang, Wentao
Bentzien, Frauke
Cancilla, Belinda
Lutman, Jeffery
Chu, Felix
Jackman, Lisa
Shi, Yongchang
Yu, Peiwen
Wang, Jing
Aftab, Dana T.
Jaeger, Christopher T.
Meyer, Stephanie M.
De Costa, Anushka
Engell, Kelly
Chen, Jason
Martini, Jean-Francois
Joly, Alison H.
CLINICAL CANCER RESEARCH, 2007, 13 (12) : 3713 - 3723
[2] The T790M "gatekeeper" mutation in EGFR mediates resistance to low concentrations of an irreversible EGFR inhibitor
Godin-Heymann, Nadia
LlIkus, Lindsey
Brannigan, Brian W.
McDermott, Ultan
Lamb, Jennifer
Maheswaran, Shyamala
Settleman, Jeffrey
Haber, Daniel A.
MOLECULAR CANCER THERAPEUTICS, 2008, 7 (04) : 874 - 879
[3] Structural Basis of AZD9291 Selectivity for EGFR T790M
Yan, Xiao-E
Ayaz, Pelin
Zhu, Su-Jie
Zhao, Peng
Liang, Ling
Zhang, Casey H.
Wu, Ya-Chuang
Li, Je-Luen
Choi, Hwan Geun
Huang, Xin
Shan, Yibing
Shaw, David E.
Yun, Cai-Hong
JOURNAL OF MEDICINAL CHEMISTRY, 2020, 63 (15) : 8502 - 8511
[4] The EGFR gatekeeper mutation T790M is present in selected patients with early breast cancer
Bemanian, Vahid
Sauer, Torill
Touma, Joel
Lindstedt, Bjorn A.
Chen, Ying
Odegard, Hilde P.
Bukholm, Ida R.
Geisler, Jurgen
CANCER RESEARCH, 2015, 75
[5] Novel T790M mutant-selective EGFR kinase inhibitors
不详
PHARMACOGENOMICS, 2010, 11 (06) : 744 - 744
[6] Novel mutant-selective EGFR kinase inhibitors against EGFR T790M
Zhou, Wenjun
Ercan, Dalia
Chen, Liang
Yun, Cai-Hong
Li, Danan
Capelletti, Marzia
Cortot, Alexis B.
Chirieac, Lucian
Iacob, Roxana E.
Padera, Robert
Engen, John R.
Wong, Kwok-Kin
Eck, Michael J.
Gray, Nathanael S.
Jaenne, Pasi A.
NATURE, 2009, 462 (7276) : 1070 - 1074
[7] Novel mutant-selective EGFR kinase inhibitors against EGFR T790M
Wenjun Zhou
Dalia Ercan
Liang Chen
Cai-Hong Yun
Danan Li
Marzia Capelletti
Alexis B. Cortot
Lucian Chirieac
Roxana E. Iacob
Robert Padera
John R. Engen
Kwok-Kin Wong
Michael J. Eck
Nathanael S. Gray
Pasi A. Jänne
Nature, 2009, 462 : 1070 - 1074
[8] Shades of T790M: Intratumor Heterogeneity in EGFR-Mutant Lung Cancer
Ichihara, Eiki
Lovly, Christine M.
CANCER DISCOVERY, 2015, 5 (07) : 694 - 696
[9] Selection for the EGFR T790M gatekeeper resistance mutation may vary among different small molecule EGFR TKIs
Chmielecki, Juliann
Pietanza, Maria C.
Kris, Mark
Miller, Vincent
Stout, Thomas
Pao, William
CANCER RESEARCH, 2010, 70
[10] Molecular Dynamics Analysis of Binding of Kinase Inhibitors to WT EGFR and the T790M Mutant
Park, Jiyong
McDonald, Joseph J.
Petter, Russell C.
Houk, K. N.
JOURNAL OF CHEMICAL THEORY AND COMPUTATION, 2016, 12 (04) : 2066 - 2078

← 1 2 3 4 5 →